This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Progenics Pharmaceuticals Inc (PGNX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 119.30M 65.86M 58.84M 70.10M
Receivables 109.00K 2.88M 6.94M 1.52M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 2.52M 1.94M 1.69M 919.00K
Total Current Assets 121.93M 70.68M 67.47M 72.54M
Property, Plant & Equipment, Gross 12.37M 14.53M 15.67M 26.10M
Accumulated Depreciation & Depletion 9.82M 12.12M 12.27M 22.06M
Property, Plant & Equipment, Net 2.55M 2.41M 3.40M 4.04M
Intangibles 28.70M 31.38M 0.00 0.00
Other Non-Current Assets 157.00K 2.36M 3.39M 3.53M
Total Non-Current Assets 39.11M 43.86M 8.84M 7.57M
Liabilities & Shareholder Equity
Total Assets 161.04M 114.54M 76.31M 80.11M
Accounts Payable 1.04M 793.00K 229.00K 309.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 431.00K 115.00K 115.00K
Total Current Liabilities 6.68M 6.63M 8.66M 6.65M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 11.33M 12.32M 0.00 0.00
Other Non-Current Liabilities 18.11M 16.61M 1.08M 1.66M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 29.44M 28.94M 1.08M 1.66M
Total Liabilities 36.13M 35.56M 9.74M 8.31M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 124.91M 78.98M 66.57M 71.80M
Common Par 91.00K 79.00K 61.00K 44.00K
Additional Paid In Capital 589.83M 548.51M 493.61M 463.44M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -462.27M -466.68M -424.10M -388.67M
Treasury Stock -2.74M -2.74M -2.74M -2.74M
Other Equity Adjustments 0.00 -192.00K -260.00K -268.00K
Total Capitalization 124.91M 78.98M 66.57M 71.80M
Total Equity 124.91M 78.98M 66.57M 71.80M
Total Liabilities & Stock Equity 161.04M 114.54M 76.31M 80.11M
Total Common Shares Outstanding 69.63M 60.83M 46.57M 33.85M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 200.00K 200.00K 200.00K 200.00K
Basic Weighted Shares Outstanding 68.18M 55.80M 34.75M 33.38M
Diluted Weighted Shares Outstanding 68.24M 55.80M 34.75M 33.49M
Number of Employees 57 69 76 105
Number of Part-Time Employees 0 0 0 0

PGNX Progenics Pharmaceuticals Inc

Chart of PGNX

Analysts Ratings for PGNX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

PGNX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs